Pregabalin Capsule
Product Images NDC 71205-608

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71205-608). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-608-60 (Pregabalin 150mg 90s)

This is a description of a medication package containing Pregabalin 150mg. The package contains 60 capsules, and the medication is dispensed with an accompanying medication guide. The medication is only available through a prescription, and the package is labeled with the manufacturer's information, including the lot number and expiration date. The medication comes in hard white capsules with imprinted markings, and the package includes a warning to keep the medication out of reach of children.*

FDA Label Image

Pregabalin-equation (Pregabalin Equation)

This appears to be a medical formula for estimating creatinine clearance (CLCr) based on age, weight, and serum creatinine levels. The formula is adjusted for female patients with a correction factor of 0.85. However, without further context or information, it is unclear how this formula would be used or what it is intended to diagnose or estimate.*

FDA Label Image

Pregabalin-figure-6 (Pregabalin Figure 6)

This text describes the results from three different studies (E1, E2, and E3) comparing the effectiveness of different doses of a certain medication to a placebo. The results are expressed as percentages and numerical values, and indicate that certain doses of the medication had a statistically significant effect compared to the placebo. However, without knowing what the medication is or what it's being used to treat, it's difficult to provide a more specific description.*

FDA Label Image

Pregabalin-figure-7 (Pregabalin Figure 7)

FDA Label Image

Study Dpn 1 (Pregabalin Image 1)

FDA Label Image

Study Sci 1 (Pregabalin Image 10)

FDA Label Image

Pain Intensity-study Sci 2 (Pregabalin Image 11)

FDA Label Image

Study Dpn 2 (Pregabalin Image 2)

FDA Label Image

Study Phn 1 (Pregabalin Image 3)

FDA Label Image

Study Phn 2 (Pregabalin Image 4)

FDA Label Image

Study Phn 3 (Pregabalin Image 5)

FDA Label Image

Fibromyalgia Study F1 (Pregabalin Image 8)

This appears to be a table showing the percent of patients who experienced an improvement in pain from baseline when taking different doses of pregabalin. The table lists three different daily doses of pregabalin (450mg, 300mg, and 50mg), along with a fourth option labeled "placebo". The percentage of improvement in pain appears to range from 20% to 100% depending on the dose of pregabalin taken.*

FDA Label Image

Fibromyalgia Study F2 (Pregabalin Image 9)

FDA Label Image

Pregabalin Structure (Pregabalin Srtuc 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.